These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11313)

  • 41. Competing for water: A new approach to understand disintegrant performance.
    Ekmekciyan N; Tuglu T; El-Saleh F; Muehlenfeld C; Stoyanov E; Quodbach J
    Int J Pharm; 2018 Sep; 548(1):491-499. PubMed ID: 30018010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of granulation on super disintegrant performance.
    Zhao N; Augsburger LL
    Pharm Dev Technol; 2006 Feb; 11(1):47-53. PubMed ID: 16544908
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings: Evaluation of some tablet disintegrants and the effect of disintegrant type on the dissolution efficiency/compressional force relation.
    Khan KA; Rooke DJ
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():106P-107P. PubMed ID: 4156697
    [No Abstract]   [Full Text] [Related]  

  • 45. Disintegrant Selection in Hydrophobic Tablet Formulations.
    Bauhuber S; Warnke G; Berardi A
    J Pharm Sci; 2021 May; 110(5):2028-2037. PubMed ID: 33181185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet.
    Sadeghi M; Hemmati S; Hamishehkar H
    Drug Dev Ind Pharm; 2016; 42(5):769-75. PubMed ID: 26289005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Impact of Disintegrant Type, Surfactant, and API Properties on the Processability and Performance of Roller Compacted Formulations of Acetaminophen and Aspirin.
    Zhao J; Koo O; Pan D; Wu Y; Morkhade D; Rana S; Saha P; Marin A
    AAPS J; 2017 Sep; 19(5):1387-1395. PubMed ID: 28608238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
    Adeoye O; Alebiowu G
    Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Review of Disintegrants and the Disintegration Phenomena.
    Desai PM; Liew CV; Heng PWS
    J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging.
    Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A
    Int J Pharm; 2015; 486(1-2):242-51. PubMed ID: 25835268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of disintegrants in different substrate physical form on dimensional recovery of multi-component tablet.
    Sarkar S; Ooi SM; Liew CV; Tan BX; Heng PW
    Int J Pharm; 2014 Nov; 475(1-2):558-65. PubMed ID: 25218488
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of disintegrants functionality for orodispersible mini tablets.
    Soulairol I; Chaheen M; Tarlier N; Aubert A; Bataille B; Sharkawi T
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1770-1779. PubMed ID: 28581832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incompatibility of croscarmellose sodium with alkaline excipients in a tablet formulation.
    Bindra DS; Stein D; Pandey P; Barbour N
    Pharm Dev Technol; 2014 May; 19(3):285-9. PubMed ID: 23528069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of molecular structure variation on the disintegrant action of sodium starch glycolate.
    Rudnic EM; Kanig JL; Rhodes CT
    J Pharm Sci; 1985 Jun; 74(6):647-50. PubMed ID: 4020652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic classification of tablet disintegrants by water uptake and force development kinetics.
    Quodbach J; Kleinebudde P
    J Pharm Pharmacol; 2014 Oct; 66(10):1429-38. PubMed ID: 24943882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance of tablet disintegrants: impact of storage conditions and relative tablet density.
    Quodbach J; Kleinebudde P
    Pharm Dev Technol; 2015; 20(6):762-8. PubMed ID: 24848093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of starches on the mechanical properties of paracetamol tablet formulations. II. Sorghum and plantain starches as disintegrants.
    Alebiowu G; Itiola OA
    Acta Pharm; 2003 Dec; 53(4):313-20. PubMed ID: 14769238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimization of a formulation for direct compression using a simplex lattice design.
    Van Kamp HV; Bolhuis GK; Lerk CF
    Pharm Weekbl Sci; 1987 Oct; 9(5):265-73. PubMed ID: 3432036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of liquisolid formulations on dissolution of naproxen.
    Tiong N; Elkordy AA
    Eur J Pharm Biopharm; 2009 Nov; 73(3):373-84. PubMed ID: 19679184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.